These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1279 related items for PubMed ID: 15809062
1. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells. Yi HK, Kim SY, Hwang PH, Kim CY, Yang DH, Oh Y, Lee DY. Biochem Biophys Res Commun; 2005 May 13; 330(3):760-7. PubMed ID: 15809062 [Abstract] [Full Text] [Related]
2. PTEN/MMAC1 enhances the growth inhibition by anticancer drugs with downregulation of IGF-II expression in gastric cancer cells. Hwang PH, Kim SY, Lee JC, Kim SJ, Yi HK, Lee DY. Exp Mol Med; 2005 Oct 31; 37(5):391-8. PubMed ID: 16264263 [Abstract] [Full Text] [Related]
3. Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells. Yi HK, Hwang PH, Yang DH, Kang CW, Lee DY. Eur J Cancer; 2001 Nov 31; 37(17):2257-63. PubMed ID: 11677116 [Abstract] [Full Text] [Related]
4. Insulin-like growth factor binding protein-3 inhibits the growth of non-small cell lung cancer. Lee HY, Chun KH, Liu B, Wiehle SA, Cristiano RJ, Hong WK, Cohen P, Kurie JM. Cancer Res; 2002 Jun 15; 62(12):3530-7. PubMed ID: 12068000 [Abstract] [Full Text] [Related]
5. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. St-Germain ME, Gagnon V, Mathieu I, Parent S, Asselin E. Int J Oncol; 2004 May 15; 24(5):1311-24. PubMed ID: 15067356 [Abstract] [Full Text] [Related]
6. Insulin-like growth factor-I inhibits cell growth in the a549 non-small lung cancer cell line. Kodama Y, Baxter RC, Martin JL. Am J Respir Cell Mol Biol; 2002 Sep 15; 27(3):336-44. PubMed ID: 12204896 [Abstract] [Full Text] [Related]
7. Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells. Wan X, Helman LJ. Oncogene; 2003 Nov 06; 22(50):8205-11. PubMed ID: 14603261 [Abstract] [Full Text] [Related]
8. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells. Kim MS, Kim SY, Arunachalam S, Hwang PH, Yi HK, Nam SY, Lee DY. Biochem Biophys Res Commun; 2009 Jul 17; 385(1):38-43. PubMed ID: 19427836 [Abstract] [Full Text] [Related]
9. PTEN/MMAC1 overexpression decreases insulin-like growth factor-I-mediated protection from apoptosis in neuroblastoma cells. van Golen CM, Schwab TS, Ignatoski KM, Ethier SP, Feldman EL. Cell Growth Differ; 2001 Jul 17; 12(7):371-8. PubMed ID: 11457734 [Abstract] [Full Text] [Related]
10. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells. Tanno S, Tanno S, Mitsuuchi Y, Altomare DA, Xiao GH, Testa JR. Cancer Res; 2001 Jan 15; 61(2):589-93. PubMed ID: 11212254 [Abstract] [Full Text] [Related]
11. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling. Zhang D, Brodt P. Oncogene; 2003 Feb 20; 22(7):974-82. PubMed ID: 12592384 [Abstract] [Full Text] [Related]
12. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells. Sivaprasad U, Fleming J, Verma PS, Hogan KA, Desury G, Cohick WS. Endocrinology; 2004 Sep 20; 145(9):4213-21. PubMed ID: 15192040 [Abstract] [Full Text] [Related]
13. PTEN-induction in U251 glioma cells decreases the expression of insulin-like growth factor binding protein-2. Levitt RJ, Georgescu MM, Pollak M. Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1056-61. PubMed ID: 16154532 [Abstract] [Full Text] [Related]
14. Up-regulation of insulin-like growth factor binding protein-5 is independent of muscle cell differentiation, sensitive to rapamycin, but insensitive to wortmannin and LY294002. Rousse S, Montarras D, Pinset C, Dubois C. Endocrinology; 1998 Apr 04; 139(4):1487-93. PubMed ID: 9528925 [Abstract] [Full Text] [Related]
15. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells. Le H, Arnold JT, McFann KK, Blackman MR. Am J Physiol Endocrinol Metab; 2006 May 04; 290(5):E952-60. PubMed ID: 16368782 [Abstract] [Full Text] [Related]
16. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner. Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D. Cell Signal; 2013 Jun 04; 25(6):1395-402. PubMed ID: 23499909 [Abstract] [Full Text] [Related]
17. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway. Zhang J, Choi Y, Mavromatis B, Lichtenstein A, Li W. Oncogene; 2003 Sep 18; 22(40):6289-95. PubMed ID: 13679867 [Abstract] [Full Text] [Related]
19. Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis. Gomez-Manzano C, Fueyo J, Jiang H, Glass TL, Lee HY, Hu M, Liu JL, Jasti SL, Liu TJ, Conrad CA, Yung WK. Ann Neurol; 2003 Jan 18; 53(1):109-17. PubMed ID: 12509854 [Abstract] [Full Text] [Related]
20. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells. Choi Y, Zhang J, Murga C, Yu H, Koller E, Monia BP, Gutkind JS, Li W. Oncogene; 2002 Aug 08; 21(34):5289-300. PubMed ID: 12149650 [Abstract] [Full Text] [Related] Page: [Next] [New Search]